FE:NYSEFirstEnergy Corp. Analysis
Data as of 2026-05-22 - not real-time
$45.50
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
FirstEnergy trades at $45.5, about 15% above its DCF‑derived fair value of $33.9, suggesting limited upside from a valuation standpoint. The stock’s trailing P/E of 24.7 exceeds the industry average of 21.8, while forward P/E contracts to 15.4, indicating earnings are expected to improve. Revenue growth of 11.6% and operating margin of 20.5% demonstrate solid operational performance. However, free cash flow is negative (-$1.84B) and the payout ratio sits at 96.7%, raising concerns about dividend sustainability. The dividend yield of 4.09% remains attractive but may be at risk if cash generation does not improve.
Technicals show the price below the 20‑day (46.08) and 50‑day (48.65) moving averages, with RSI at 41 and a bullish MACD histogram, pointing to a neutral‑to‑slightly bullish short‑term bias. Support sits at $43.73 and resistance near $49.97, giving a modest upside corridor. Recent analyst upgrades from TD Cowen and Goldman Sachs to “Buy” with price targets around $54‑$55 add to the upside potential of roughly 15‑20%. Nevertheless, the sector’s regulated nature introduces medium regulatory risk, and the company’s high debt‑to‑equity of ~199 amplifies balance‑sheet concerns. Overall, the stock appears fairly priced on a growth‑value blend basis, with dividend sustainability questionable, suggesting a cautious but optimistic stance.
Technicals show the price below the 20‑day (46.08) and 50‑day (48.65) moving averages, with RSI at 41 and a bullish MACD histogram, pointing to a neutral‑to‑slightly bullish short‑term bias. Support sits at $43.73 and resistance near $49.97, giving a modest upside corridor. Recent analyst upgrades from TD Cowen and Goldman Sachs to “Buy” with price targets around $54‑$55 add to the upside potential of roughly 15‑20%. Nevertheless, the sector’s regulated nature introduces medium regulatory risk, and the company’s high debt‑to‑equity of ~199 amplifies balance‑sheet concerns. Overall, the stock appears fairly priced on a growth‑value blend basis, with dividend sustainability questionable, suggesting a cautious but optimistic stance.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- price below short‑term moving averages
- overvaluation relative to DCF
- high dividend payout ratio
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- analyst upgrades and price target upside
- solid revenue growth and operating margins
- potential earnings improvement reflected in forward P/E
Long Term
> 3 yearsNeutral
Model confidence: 7/10
Key Factors
- regulated utility stability
- balance‑sheet leverage concerns
- uncertain dividend sustainability
Key Metrics & Analysis
Financial Health
Revenue Growth11.60%
Profit Margin6.94%
P/E Ratio24.7
ROE9.46%
ROA3.76%
Debt/Equity198.92
P/B Ratio2.1
Op. Cash Flow$3.2B
Free Cash Flow$-1835124992
Industry P/E21.8
Technical Analysis
TrendNeutral
RSI41.0
Support$43.73
Resistance$49.97
MA 20$46.08
MA 50$48.65
MA 200$46.65
MACDBullish
VolumeDecreasing
Fear & Greed Index90.93
Valuation
Fair Value$33.87
Target Price$52.46
Upside/Downside15.30%
GradeOvervalued
TypeBlend
Dividend Yield4.09%
Risk Assessment
Beta-0.01
Volatility18.58%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.